You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 264 No. 12, September 26, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drinking Coffee and Carbonated Beverages Blocks Absorption of Nicotine From Nicotine Polacrilex Gum

Jack E. Henningfield, PhD; Aleksandras Radzius; Thomas M. Cooper, DDS; Richard R. Clayton, PhD

JAMA. 1990;264(12):1560-1564.


Abstract

Patients failing to obtain benefit from nicotine polacrilex gum in their efforts to quit smoking may be inadvertently blocking nicotine absorption. Effective nicotine absorption depends on the mildly alkaline saliva that is produced when buffering agents in the polacrilex are released along with nicotine as the polacrilex is chewed. We found that intermittent mouth rinsing with coffee or cola, but not distilled water, substantially reduced salivary pH and nicotine absorption. Because many commonly consumed substances were also found to be highly acidic, we recommend that patients do not ingest any substance during or immediately before nicotine polacrilex use.

(JAMA. 1990;264:1560-1564)



Author Affiliations

From the Clinical Pharmacology Branch, National Institute on Drug Abuse, Addiction Research Center, Baltimore, Md (Dr Henningfield and Mr Radzius); Department of Community Dentistry, Albert B. Chandler Medical Center, Lexington, Ky (Dr Cooper); and Departments of Dentistry (Dr Cooper) and Sociology (Dr Clayton), University of Kentucky, Lexington.


Footnotes

Reprint requests to NIDA Addiction Research Center, PO Box 5180, Baltimore, MD 21224 (Dr Henningfield).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Smoking cessation pharmacotherapy
Frishman
Ther Adv Cardiovasc Dis 2009;3:287-308.
ABSTRACT  

Pharmacotherapy for Nicotine Dependence
Henningfield et al.
CA Cancer J Clin 2005;55:281-299.
ABSTRACT | FULL TEXT  

Pharmacokinetics and pharmacodynamics of moist snuff in humans
Fant et al.
Tobacco Control 1999;8:387-392.
ABSTRACT | FULL TEXT  

Nicotine Medications for Smoking Cessation
Henningfield
NEJM 1995;333:1196-1203.
FULL TEXT  

Effectiveness of the 4-mg Dose of Nicotine Polacrilex for the Initial Treatment of High-Dependent Smokers
Sachs
Arch Intern Med 1995;155:1973-1980.
ABSTRACT  

Cigarette Smoking, Nicotine Addiction, and Its Pharmacologic Treatment
Lee and D'Alonzo
Arch Intern Med 1993;153:34-48.
ABSTRACT  

Tobacco Dependence and the Nicotine Patch: Clinical Guidelines for Effective Use
Fiore et al.
JAMA 1992;268:2687-2694.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.